Document hub

Our international presence

Return to Hikma.com
Contact Us

Popular searches

High-quality sterile injectable manufacturing

Fill-finish capabilities for vials, prefilled syringes, infusion bags, and ampoules across all formulation types. 500+ million unit annual capacity in EU and US

Key capabilites
Product General formulation liquid solutions | General formulation lyophilisation | Liquid and lyophilised biologics | Sterile emulsions and suspensions | Oil based products | Liquid and lyophilised cytotoxic and high-containment products | Cephalosporins | Controlled substances
Technology IV Bags | Prefilled syringes | Liquid vials| Lyophilised vials | Ampoules
Excellent Quality Record US FDA | EMA | Japan FDA | Jordan FDA | Korea | GCC | ANVISA
Integrated services Development phase | Scale-up processes | Fill and finish
Distribution 50+ markets

Our operations 

It is the global hub for the Injectables business. It includes:
• Three segregated plants for the manufacturing of general formulation products, high containment products and cephalosporins antibiotics
• Our capabilities cover different forms and technologies, including vials and
ampoules, prefilled syringes, IV bags, emulsions/suspensions and oils
• The site services, the US, EU, UK and MENA markets.

Our liquid and lyophilisation cytotoxic hub for the US, Europe and MENA.

Our lyophilisation hub for Europe and MENA.

It produces a variety of injectables products in various forms, including prefilled syringes.

Our newest site for septic bags filling and lyophilisation for the US.

High-quality prefilled manufacturing operations in the US 

Get in touch

Contact us to discuss your injectable CMO needs and book a tour in our facilities.

Related content

Explore more